Chemicals News Today

BASF India, Green Worms, and IPUA inaugurated a CSR-funded polyurethane waste recycling facility in Keralam, converting industrial footwear waste into floor mats for 4,000 schoolchildren and creating local jobs.

Henri Kagan and Kenso Soai won the 2026 Nobel Prize in Chemistry for asymmetric synthesis. Indian scientists highlight how their breakthrough on mirror-image molecules can reduce medicine manufacturing costs.

India's water treatment plants struggle to detect and remove harmful 'forever chemicals' or PFAS. With no specific regulations or drinking water limits currently, experts urge urgent baseline monitoring and strict policy interventions.

Avid Organics plans a $50 million investment by 2035 to establish its first US manufacturing facility, targeting production of glycine and glycolic acid by 2028 to strengthen North American supply.

West Bengal is set to inaugurate a Rs 6,000-crore phenol and acetone plant in Haldia with a 3.5 lakh tonnes capacity, aimed at reducing import dependence and creating local jobs.

Karnataka farmers blocked the Pune-Bengaluru National Highway, demanding a sugarcane price of Rs 5,500-6,000 per tonne, higher sugar MSP, and increased ethanol procurement after talks with the Centre failed.

India's Avid Organics plans a $50 million investment to build its first US manufacturing plant by 2028, producing glycine and glycolic acid to strengthen North American operations.

Researchers developed a sustainable method using bulk nanobubbles of 150-200 nanometers to boost paracetamol manufacturing yields by up to 65% while reducing crystal size without hazardous chemical additives.

Mysuru-based NuSynth Technologies has raised ₹36.5 crore in seed funding from Avaana Capital and Shastra VC to develop proprietary process innovation and synthetic route redesign for pharmaceuticals and electronics chemicals.

Mysuru-based startup NuSynth Technologies has raised Rs 36.5 crore in a Seed funding round co-led by Avaana Capital and Shastra VC to strengthen India's chemical R&D and innovation capabilities for the pharmaceutical sector.